A Randomized Phase III Trial of Weekly Paclitaxel Compared to Weekly Nanoparticle Albumin Bound Nab-Paclitaxel or Ixabepilone With or Without Bevacizumab as First-Line Therapy for Locally Recurrent or Metastatic Breast Cancer
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 09 Jul 2015
At a glance
- Drugs Ixabepilone (Primary) ; Paclitaxel (Primary) ; Bevacizumab
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 10 Apr 2013 Planned end date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 07 Feb 2013 New source identified and integrated (Mayo Clinic: 08-005726).
- 05 Jun 2012 Results presented at the 48th Annual Meeting of the American Society of Clinical Oncology.